Extended safety check for lifelong hormone disorder treatment
Disease control
Completed
This study followed 76 adults with congenital adrenal hyperplasia (CAH) to check the long-term safety of a medication called Chronocort. Participants either continued taking Chronocort or switched to it from their standard therapy. The main goal was to monitor for side effects an…
Phase: PHASE3 • Sponsor: Neurocrine UK Limited • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC